CRIPPA, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 4.677
EU - Europa 3.901
AS - Asia 2.708
SA - Sud America 407
AF - Africa 75
Continente sconosciuto - Info sul continente non disponibili 66
OC - Oceania 9
Totale 11.843
Nazione #
US - Stati Uniti d'America 4.559
RU - Federazione Russa 1.450
GB - Regno Unito 1.101
SG - Singapore 1.076
CN - Cina 785
BR - Brasile 335
IT - Italia 255
VN - Vietnam 249
DE - Germania 235
HK - Hong Kong 231
SE - Svezia 187
FI - Finlandia 173
IE - Irlanda 165
FR - Francia 155
KR - Corea 82
BD - Bangladesh 79
CA - Canada 67
UA - Ucraina 44
NL - Olanda 35
IN - India 31
TR - Turchia 30
AR - Argentina 29
JP - Giappone 28
NG - Nigeria 26
MX - Messico 24
ID - Indonesia 21
BE - Belgio 19
IQ - Iraq 16
PL - Polonia 16
ZA - Sudafrica 13
AT - Austria 12
EC - Ecuador 12
PK - Pakistan 12
SA - Arabia Saudita 11
LT - Lituania 9
AE - Emirati Arabi Uniti 8
AU - Australia 8
CZ - Repubblica Ceca 8
ES - Italia 8
PH - Filippine 8
TG - Togo 8
CL - Cile 7
CO - Colombia 7
IR - Iran 7
MA - Marocco 7
RO - Romania 7
JM - Giamaica 6
BJ - Benin 5
IL - Israele 5
PY - Paraguay 5
UZ - Uzbekistan 5
VE - Venezuela 5
AL - Albania 4
CH - Svizzera 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
EE - Estonia 3
EU - Europa 3
JO - Giordania 3
LB - Libano 3
MY - Malesia 3
OM - Oman 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
BG - Bulgaria 2
EG - Egitto 2
HN - Honduras 2
HU - Ungheria 2
KE - Kenya 2
KH - Cambogia 2
MN - Mongolia 2
NI - Nicaragua 2
NP - Nepal 2
PE - Perù 2
RE - Reunion 2
RS - Serbia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BO - Bolivia 1
CI - Costa d'Avorio 1
DJ - Gibuti 1
GA - Gabon 1
GF - Guiana Francese 1
IS - Islanda 1
KN - Saint Kitts e Nevis 1
KZ - Kazakistan 1
LC - Santa Lucia 1
ME - Montenegro 1
NC - Nuova Caledonia 1
NO - Norvegia 1
PA - Panama 1
QA - Qatar 1
SC - Seychelles 1
SI - Slovenia 1
SO - Somalia 1
Totale 11.780
Città #
Southend 956
Singapore 603
Moscow 522
Ashburn 514
San Jose 496
Jacksonville 417
Chandler 393
Dallas 336
Woodbridge 292
Ann Arbor 233
Hong Kong 231
Dublin 165
Houston 156
Council Bluffs 155
Beijing 115
Verona 112
The Dalles 107
Ho Chi Minh City 82
Wilmington 75
New York 66
Los Angeles 65
Munich 65
Lawrence 64
Princeton 64
Hanoi 58
Jinan 55
Santa Clara 55
Nanjing 47
Shenyang 47
Buffalo 40
Hebei 39
Helsinki 36
Sindelfingen 35
Tianjin 34
São Paulo 32
Columbus 29
Milan 29
Haikou 27
Abuja 26
Orem 26
Tokyo 26
Toronto 25
Seattle 23
Lancaster 22
London 22
Redondo Beach 21
Zhengzhou 20
Brussels 18
Chicago 18
Ningbo 18
Turku 18
Da Nang 17
Nanchang 17
Changsha 16
Montreal 16
San Francisco 16
Frankfurt am Main 15
Rome 15
Taiyuan 15
Belo Horizonte 14
Haiphong 14
Taizhou 14
Warsaw 14
Denver 13
Guangzhou 13
Amsterdam 12
Chennai 12
Hangzhou 12
Jiaxing 12
Rio de Janeiro 12
Brooklyn 11
Stockholm 11
Atlanta 10
Boardman 10
Falls Church 10
Grafing 10
Lanzhou 10
Manchester 10
Mexico City 10
Seoul 10
Vienna 10
Norwalk 9
Shanghai 9
Barnet 8
Boston 8
Charlotte 8
Fairfield 8
Jakarta 8
Johannesburg 8
Lappeenranta 8
Lomé 8
Jeddah 7
Poplar 7
Auburn Hills 6
Brasília 6
Düsseldorf 6
Hải Dương 6
Paris 6
Washington 6
Baghdad 5
Totale 7.648
Nome #
"Paraduodenal" pancreatitis: results of surgery on 58 consecutives patients from a single institution. 257
Amylase value in drains after pancreatic resection as predictive factor of postoperative pancreatic fistula: results of a prospective study in 137 patients. 252
Differences between main-duct and branch-duct intraductal papillary mucinous neoplasms of the pancreas 242
Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate? Results of a prospective protocol on the management of 109 consecutive patients. 218
UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR AS A NEW USEFUL MARKER IN PANCREATIC CANCER: PRELIMINARY RESULTS 217
Acute pancreatitis at the beginning of the 21st century: the state of the art. 215
PTPRG Expression Correlates with Tolerogenic Phenotype in Dendritic Cells Derived from Pancreatic Cancer Patients 205
Ampullary somatostatinomas and jejunal gastrointestinal stromal tumor in a patient with Von Recklinghausen's disease. 205
Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms 204
Anastomotic leakage in pancreatic surgery. 200
Clinical and biological behavior of pancreatic solid pseudopapillary tumors: report on 31 consecutive patients. 199
Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. 197
Anastomotic leakage in pancreatic surgery. 196
Laparoscopic rectal resection for severe endometriosis of the mid and low rectum: technique and operative results. 193
THE VALUE OF (18)FLUOR-DEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY (18FDG-PET/CT) IN RESECTABLE PANCREATIC CANCER: A PROSPECTIVE STUDY 191
Enucleation of pancreatic neoplasms. 188
Actual malignancy risk of either operated or non-operated presumed mucinous cystic neoplasms of the pancreas under surveillance 187
Primary tumour resection in metastatic nonfunctioning pancreatic endocrine carcinomas. 186
SILS cholecystectomy, early experience of a single institution: pilot study of 21 cases. 185
ASO Visual Abstract: Surgery for IPMN of the Pancreas—Preoperative Factors Tipping the Scale of Decision-Making 182
Anastomotic leakage in pancreatic surgery. 182
Parenchyma-preserving resections for small nonfunctioning pancreatic endocrine tumors. 181
Surveillance for Presumed BD-IPMN of the Pancreas: Stability, Size, and Age Identify Targets for Discontinuation 180
Incidental diagnosis as prognostic factor in different tumor stages of nonfunctioning pancreatic endocrine tumors 178
Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas: Interim analysis of the prospective PANCY survey 172
Parenchyma-sparing resections for pancreatic neoplasms. 171
Pancreatoblastoma in adults: a review of the literature. 171
Futility of Up-Front Resection for Anatomically Resectable Pancreatic Cancer 171
Middle pancreatectomy: indications, short- and long-term operative outcomes. 168
Surgical management of insulinomas: short- and long-term outcomes after enucleations and pancreatic resections. 166
Contrast-Enhanced Ultrasonography of the Pancreas 165
Extent of surgical resections for intraductal papillary mucinous neoplasms. 165
Enucleation of pancreatic neoplasms 163
Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma. 160
Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. 159
Early Versus Late Drain Removal After Standard Pancreatic Resections Results of a Prospective Randomized Trial 157
Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy 155
Implications of the new histological classification (WHO 2010) for pancreatic neuroendocrine neoplasms. 155
Total pancreatectomy: indications, different timing, and perioperative and long-term outcomes. 154
Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling 151
Open pancreaticogastrostomy after pancreaticoduodenectomy: a pilot study. 147
The role of laparoscopy in advanced pancreatic cancer diagnosis. 146
Verona Evidence-Based Meeting (EBM) 2020 on Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: Meeting Report 145
Splenic Artery Invasion in Pancreatic Adenocarcinoma of the Body and Tail - a Novel Prognostic Parameter for Patients Selection 145
Long-term outcomes and prognostic factors in neuroendocrine carcinomas of the pancreas: Morphology matters 144
ASO Visual Abstract: Ca 19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma 143
Surgical strategy in the treatment of pancreatic neuroendocrine tumors. 143
Results of First-round of Surveillance in Individuals at High-risk of Pancreatic Cancer from the AISP (Italian Association for the Study of the Pancreas) Registry 143
Pleomorphic liposarcoma of the axilla metastatic to the pancreas. 142
Pancreatic anastomotic leakage after pancreaticoduodenectomy in 1,507 patients: a report from the Pancreatic Anastomotic Leak Study Group. 141
Cure Probabilities After Resection of Pancreatic Ductal Adenocarcinoma: A Multi-Institutional Analysis of 2554 Patients 140
Surgery for Intraductal Papillary Mucinous Neoplasms of the Pancreas: Preoperative Factors Tipping the Scale of Decision-Making 138
Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. 138
Invasive intraductal papillary mucinous carcinomas of the pancreas: predictors of survival and the role of lymph node ratio 138
Surgical treatment of pancreatic tumors in childhood and adolescence: uncommon neoplasms with favorable outcome. 136
Pancreatic insufficiency after different resections for benign tumours. 135
Surgical strategy in the treatment of pancreatic neuroendocrine tumors. 134
Guidelines on Pancreatic Cystic Neoplasms: Major Inconsistencies With Available Evidence and Clinical Practice- Results From an International Survey 129
Intraductal papillary mucinous neoplasms of the biliary and pancreatic ducts-A shape shifting outlook into an increasingly recognized disease. 128
Pancreatic metastasis from leiomyosarcoma of the broad ligament of the uterus. 127
Improving cytological diagnosis of pancreatic cysts: Is it clinically necessary or just the latest fashion? 118
Pancreatic cystic tumours: when to resect, when to observe 118
Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor 117
Rectal indomethacin to prevent post-ERCP pancreatitis. 116
Splenic Artery Invasion in Pancreatic Adenocarcinoma of the Body and Tail: A Novel Prognostic Parameter for Patient Selection 111
Surgical strategy in the treatment of pancreatic neuroendocrine tumors 109
Pattern of disease recurrence and treatment after surgery for nonfunctioning well-differentiated pancreatic neuroendocrine tumors 106
Peptide receptor radionuclide therapy as neoadjuvant therapy for resectable or potentially resectable pancreatic neuroendocrine neoplasms 104
ASO Author Reflections: Recurrence Following Post-neoadjuvant Pancreatectomy: How Can We Do Better? 101
Laparoscopic ileocecal resection for bowel endometriosis. 99
Real-world costs and dynamics of surveillance in patients who underwent surgery for low-risk branch duct intraductal papillary mucinous neoplasms 98
Identification of patients with branch-duct intraductal papillary mucinous neoplasm and very low risk of cancer: multicentre study 91
Intraductal papillary mucinous neoplasms (IPMNs): is it time to (sometimes) spare the knife? 90
Intraductal papillary mucinous neoplasms of the pancreas with concurrent pancreatic and periampullary neoplasms 88
The size of well differentiated pancreatic neuroendocrine tumors correlates with Ki67 proliferative index and is not associated with age 86
Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancer 66
Totale 11.843
Categoria #
all - tutte 39.171
article - articoli 37.014
book - libri 0
conference - conferenze 1.681
curatela - curatele 0
other - altro 476
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.342


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022305 0 0 0 30 14 20 15 29 21 9 57 110
2022/20231.051 80 121 103 151 89 244 27 92 108 6 24 6
2023/2024534 19 59 53 70 57 81 23 31 9 27 77 28
2024/20251.613 82 87 40 274 97 63 126 72 218 93 167 294
2025/20264.797 339 264 312 756 1.191 315 518 217 381 239 126 139
2026/2027558 45 115 145 253 0 0 0 0 0 0 0 0
Totale 11.843